Orphazyme initiates rolling submission of New Drug Application for arimoclomol with US FDA in Niemann-Pick disease Type C
May 29, 2020 01:12 ET
|
ORPHAZYME A/S
Orphazyme A/SCompany announcement No....
Orphazyme’s arimoclomol receives US Fast Track Designation in Amyotrophic Lateral Sclerosis
May 22, 2020 01:52 ET
|
ORPHAZYME A/S
Orphazyme A/SCompany announcement No....
Capital increase of 1,927 shares in Orphazyme A/S as a result of the exercise of Restricted Share Units
April 23, 2020 09:13 ET
|
ORPHAZYME A/S
Orphazyme A/SCompany announcement No....
Reporting of transactions in Orphazyme’s shares made by persons discharging managerial responsibilities
April 22, 2020 06:07 ET
|
ORPHAZYME A/S
Orphazyme A/SCompany announcement No....
Capital increase of 4,616 shares in Orphazyme A/S as a result of the exercise of Restricted Share Units
April 20, 2020 08:23 ET
|
ORPHAZYME A/S
Orphazyme A/SCompany announcement No....
Reporting of transactions in Orphazyme’s shares made by persons discharging managerial responsibilities
April 17, 2020 06:15 ET
|
ORPHAZYME A/S
Orphazyme A/SCompany announcement No....
Resolutions passed at the Annual General Meeting
March 26, 2020 12:51 ET
|
ORPHAZYME A/S
Orphazyme A/SCompany announcement No....
Orphazyme publishes listing prospectus in connection with listing of shares
March 16, 2020 03:32 ET
|
ORPHAZYME A/S
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN OR INTO THE UNITED STATES, CANADA, JAPAN OR AUSTRALIA, EXCEPT AS PERMITTED BY APPLICABLE LAW. THIS ANNOUNCEMENT IS NOT AN OFFER OF...
Reporting of transactions in Orphazyme’s shares made by persons discharging managerial responsibilities
March 11, 2020 17:25 ET
|
ORPHAZYME A/S
Orphazyme A/SCompany announcement No. 26/2020 ...
Reporting of transactions in Orphazyme’s shares made by persons discharging managerial responsibilities
March 10, 2020 09:44 ET
|
ORPHAZYME A/S
Orphazyme A/SCompany announcement No....